Using DOT1L inhibitors and a knockdown approach, we established that DOT1L was required for survival of the tumor cells by preventing the induction of apoptosis, suggesting that DOT1L is required for tumor maintenance. The gene discussed is DOT1L; the disease is neoplasm.